Result 1: Improved health status for New Mexicans

P003: Invasive pneumococcal disease rate per 100,000 population

Current Value

14.4 per 100,000

2016

Definition

Line Bar

Story Behind the Curve

Invasive pneumococcal disease (IPD) is a group of illnesses caused by bacteria called pneumococci. It can spread through the air with a cough or sneeze. The bacteria can enter the body through the mouth, throat, or eyes, and may invade parts of the body that are normally free from infection.
Nationally, pneumonia mortality in children fell by 97% in the last century, but respiratory infectious diseases continue to be leading causes of hospitalization and outpatient visits. For adults aged 65 years and older, the pneumococcal vaccine to prevent pneumonia is recommended.
For FY17, the IPD rate was 14.4 per 100,000 population in New Mexico.
The vaccine for IPD is a U.S. Centers for Disease Control (CDC) recommended vaccine and is available through the Vaccines For Children (VFC) program at no charge under insurance plans when provided by an in-network provider.
It is important for older adults to get the pneumococcal vaccine as they are more susceptible to serious and possibly life-threatening infections.

Partners

University of NM
New Mexico Immunization Coalition
Office of the Medical Investigator
NM Association for Professionals in Infection Control & Epidemiology
New Mexico Department of Health regional health promotion teams
School districts and schools
Hospital infection control practitioners
Indian Health Services
Albuquerque Tribal Epidemiology Center
CDC
National Emerging Infections Program

What Works

Pneumonia and influenza vaccination for children and adults

Strategy

Promote the pneumococcal vaccine among adults ≥65 years of age and influenza vaccine among individuals ≥6 months of age

FY17 Annual Progress Summary

The New Mexico Department of Health (NMDOH) Epidemiology and Response Division (ERD) oversees the CDC Emerging Infections Program Active Bacterial Core Surveillance project that identifies every IPD case in New Mexico, describes risk factors for contracting IPD, characterizes the demographics of IPD cases and collects isolates on IPD cases for additional laboratory testing to identify antibiotic resistance patterns and mismatch of circulating strains with serotypes covered by existing vaccines. These data are fundamental to determining the efficacy of current vaccines.
Legislation requiring all hospitalized patients >65 years of age be offered pneumococcal vaccine prior to discharge was signed into law by Gov. Martinez. The NMDOH Public Health Division (PHD), the Division of Health Improvement (DHI) and ERD are working together to construct regulatory mechanisms for compliance with the new law and to assure that vaccines given are entered in the New Mexico Statewide Immunization Information System (NMSIIS), New Mexico’s statewide vaccine registry.
The Pneumonia and Influenza Disease Rate Reduction Initiative (PI DRRT) continues to work with tribal community members and IHS clinic providers and other key preventive staff to understand key challenges to more effective immunization programs in tribes and pueblos and identify opportunities for collaboration to address the large racial disparity in disease rates unfavorable to American Indians in New Mexico.

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.